JP Morgan Maintains Neutral on Teladoc Health, Raises Price Target to $10

Benzinga · 2d ago
JP Morgan analyst Lisa Gill maintains Teladoc Health (NYSE:TDOC) with a Neutral and raises the price target from $8 to $10.